Skip to content

Clinical trials

Phase 1/2 Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1/2 Country / region: Belgium Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20101
20113
20123
20131
20141
20151
20174
20182
20191
20201
20211
20222
20232
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting9
Active, not recruiting3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Bristol-Myers Squibb2
Eli Lilly and Company2
Merck Sharp & Dohme LLC2
Sanofi2
AbbVie1
BBB-Therapeutics B.V.1
Basilea Pharmaceutica1
Cantargia AB1
Clavis Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms31
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Neoplasm Metastasis5
Neoplasms by Site5
Colorectal Neoplasms4
Head and Neck Neoplasms3
Lung Neoplasms3
Melanoma3
Neoplasms by Histologic Type3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.